Pharma and Life Sciences

PwC in the 'Pharma and Life Sciences' sector

Featured - 4 items

Mission: ‘patient centricity’: Personalised care

Whitepaper with Takeda

M&A prospects in the health industries

In sound health with an acceleration in underlying change

Regulatory and tax

Four cutting-edge digital solutions

Pharma & Life Sciences Hot Topics 2020

Find out more about each of the topics

Learn more about the future today

As a decision maker in pharmaceutical and life science you are facing major challenges every day: pressure to reduce costs and increase efficiency, urgency to innovate and leverage potential of digital and other exiting technologies to address patient needs, increasing regulation, global competition, disruption and convergence of the market. My team of passionate consultants and I would love to discuss with you how your company can successfully navigate in this demanding environment.

Dominik Hotz, Health Industries Leader Switzerland and PwC Europe

Manufacturing

A combination of regulatory, market, scientific, and technological forces is likely to mean that pharmaceutical manufacturing will undergo rapid change in the next five to ten years. There is a need for companies to consistently align investment with their vision of the manufacturing that will be needed in the future. We can help companies achieve the change required and their goals by utilising our firm's in-depth industry expertise.

Supply chain & distribution

Today companies are concerned about the cost and efficiency of their supply chain. We work with our clients to help them identify options such as outsourcing of manufacturing and distribution at an early stage of the business and product planning process.

Commercial operations

In the current environment of poor product pipelines and broader customer bases, the traditional sales and marketing model of driving revenue with ever larger sales forces is no longer sustainable. PwC can work with you to develop and implement a commercial model considering all important factors such as targeting sales and marketing resources accordingly to the customer needs and the relevant regulations – on a global, regional and local affiliate level.

Corporate & financial strategy

Companies are addressing important questions about existing and future revenue generation, and how to align operational and financial tactics to enable their chosen corporate strategy. We are working with our clients to explore strategic options and begin the process today of restructuring their business for tomorrow.

Information Technology

Together with our clients, we use a combination of industry and technology expertise to develop process improvements that assist you in getting value from technology investments.

Regulatory & compliance environment

The Pharmaceutical and Life Sciences industries are among the most heavily regulated industries in the world. We work with our clients to audit and develop management systems which enable greater transparency across the firm, inform the development of new approaches to a broad range of regulatory compliance, risk management procedures and help improve performance.

Research & development

We work closely with our clients to help formulate a new strategy for success and achieve increased performance by improving the efficiency and effectiveness of the company’s R&D operations.

Tax and Regulatory Consulting

The tax environment, especially in Pharma & Life Sciences, is continually changing. It’s becoming more difficult to comply with tax, legal and regulatory requirements in an efficient and cost-effective manner. Our deep knowledge and well-connected global network allow us to react quickly and help our clients with their daily business challenges or on unique projects.

Technology is shaping the way we do business more than ever before. Finding the right tools can make you successful. Discover PwC’s four cutting-edge digital tax and regulatory solutions for pharma & life sciences companies and how they can add value to your business, help you comply with new laws and stay up to date with upcoming changes.

Download Flyer

Research and insights

Leading a Bionic Transformation - Three new kinds of capital

What is it about companies such as Alphabet, Amazon, Apple, and Alibaba? No matter where they turn their attention — cars, banking, groceries, healthcare, media, retail, trucking — industries quail before them.

New dynamics of the pharmaceutical oncology market

Five questions to shape your strategy - How do I harness new sources of data? How can I use digital platforms? How do I navigate a changing provider landscape? How do I demonstrate value? How can I deploy commercial engagement model innovation?

Get the answers here

HRI’s Global top health industry issues: Defining the healthcare of the future

Health systems have a lot to learn from each other, other industries and from communities around the world to build resiliency in times of change. Systems will survive and thrive if they are able to connect, collaborate and create new solutions.

Contact us

Dominik Hotz

Partner Advisory, PwC Switzerland

Tel: +41 58 792 53 09